MEGAN BAUER: Open Payments
NPI 1811680333 · FREEPORT, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,124 in 62 payments from 17 companies in 2025. Trend: 2023 $24 · 2024 $507 · 2025 $1,124
Food & beverage: $1,124
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 13 | $253 |
| Merck Sharp & Dohme LLC | 9 | $174 |
| GlaxoSmithKline, LLC. | 11 | $150 |
| Exact Sciences Corporation | 4 | $83 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $75 |
| PFIZER INC. | 3 | $67 |
| Novo Nordisk Inc | 3 | $58 |
| Lilly USA, LLC | 3 | $54 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $33 |
| Otsuka America Pharmaceutical, Inc. | 2 | $33 |
Products named: FARXIGA, VERQUVO, TRELEGY ELLIPTA, ROTATEQ, Cologuard Collection Kit, JARDIANCE, SHINGRIX, TRUMENBA.
Industry payments across IL — which companies pay providers there.
